Changsu L. Park

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Longitudinal validation of ENLIGHT, an AI predictor of immunotherapy response and resistance, in pan-cancer cohorts.

Longitudinal validation of ENLIGHT, an AI predictor of immunotherapy response and resistance, in pan-cancer cohorts.

Journal: NPJ precision oncology

Published: January 26, 2026

Detecting ctDNA Using Personalized Structural Variants to Forecast Recurrence in Localized Soft Tissue Sarcoma.

Detecting ctDNA Using Personalized Structural Variants to Forecast Recurrence in Localized Soft Tissue Sarcoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 22, 2026

Detecting ctDNA Using Personalized Structural Variants to Forecast Recurrence in Localized Soft-Tissue Sarcoma.

Detecting ctDNA Using Personalized Structural Variants to Forecast Recurrence in Localized Soft-Tissue Sarcoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 22, 2026

Advances in cancer immunotherapy: adoptive cell therapy and immune cell engagers in solid tumours.

Advances in cancer immunotherapy: adoptive cell therapy and immune cell engagers in solid tumours.

Journal: British journal of cancer

Published: December 29, 2025

Efficacy and Safety of Immune Checkpoint Blockade in Locally Advanced or Metastatic Penile Cancer: A Systematic Review and Meta-Analysis.

Efficacy and Safety of Immune Checkpoint Blockade in Locally Advanced or Metastatic Penile Cancer: A Systematic Review and Meta-Analysis.

Journal: Clinical genitourinary cancer

Published: August 26, 2025

Defining the Prognostic Significance of BRAF V600E in Early-Stage Colon Cancer: A Systematic Review and Meta-Analysis.

Defining the Prognostic Significance of BRAF V600E in Early-Stage Colon Cancer: A Systematic Review and Meta-Analysis.

Journal: Current oncology (Toronto, Ont.)

Published: July 26, 2025

Moving the needle on immune checkpoint inhibitors with novel targets: are we being TIMid or LAGging behind?

Moving the needle on immune checkpoint inhibitors with novel targets: are we being TIMid or LAGging behind?

Journal: The oncologist

Published: April 01, 2025

Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis Database.

Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis Database.

Journal: Current oncology (Toronto, Ont.)

Published: July 28, 2024

A Real-World Retrospective Analysis of the Management of Advanced Urothelial Carcinoma in Canada.

A Real-World Retrospective Analysis of the Management of Advanced Urothelial Carcinoma in Canada.

Journal: Current oncology (Toronto, Ont.)

Published: December 03, 2023

Combination of Osimertinib with Concurrent Chemotherapy and Hormonal Therapy for Synchronous NSCLC, Hormone Receptor-Positive Breast Cancer, and Triple-Negative Breast Cancer: Case Report.

Combination of Osimertinib with Concurrent Chemotherapy and Hormonal Therapy for Synchronous NSCLC, Hormone Receptor-Positive Breast Cancer, and Triple-Negative Breast Cancer: Case Report.

Journal: Case reports in oncology

Published: August 10, 2023

An Unconventional Regimen of Carboplatin and Paclitaxel in Metastatic Colorectal Carcinosarcoma: A Case Report and Review of Literature.

An Unconventional Regimen of Carboplatin and Paclitaxel in Metastatic Colorectal Carcinosarcoma: A Case Report and Review of Literature.

Journal: Current oncology (Toronto, Ont.)

Published: April 10, 2023

Showing 1-11 of 11

Last Updated: 09/26/2026